In addition, 5-aza-2′deoxycytidine (5-aza-dC) is reported to restore sFRP1 expression in laryngeal cancer cell lines, which led to decreased cell proliferation and colony-forming and sensitized cells to cisplatin in vitro, and tumor growth was impaired in xenografts in vivo [261]. Here, SFRP1 is linked to neoplasm.